Application Nr Approved Date Route Status External Links
ANDA207407 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Lopinavir And Ritonavir Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection In Adults And Pediatric Patients 14 Days And Older. Limitations Of Use: Genotypic Or Phenotypic Testing And/or Treatment History Should Guide The Use Of Lopinavir And Ritonavir. The Number Of Baseline Lopinavir Resistance-Associated Substitutions Affects The Virologic Response To Lopinavir And Ritonavir [See Microbiology ( 12.4 )] . Lopinavir And Ritonavir Is An Hiv-1 Protease Inhibitor Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection In Adults And Pediatric Patients (14 Days And Older). ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Lopinavir LOPINAVIR ZINC3951740
2. Ritonavir RITONAVIR ZINC3944422

Comments